U.S. Court of Appeals for the Federal Circuit, 2015

Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.

Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided March 12, 2015

Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ ROXANE LABORATORIES, INC., Plaintiff-Appellant v. CAMBER PHARMACEUTICALS INC., INVAGEN PHARMACEUTICALS INC., Defendants-Appellees ______________________ 2014-1803 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:14-cv-04042-SRC-CLW, Judge Stanley R. Chesler. ______________________ JUDGMENT ______________________ KENNETH G. SCHULER, Latham & Watkins LLP, Chi- cago, IL, argued for plaintiff-appellant. Also represented by MARC NATHAN ZUBICK; ALEXANDER ENRICO LONG, San Diego, CA; GREGORY SOBOLSKI, San Francisco, CA; ROBERT J. GAJARSA, Washington, DC.

ROBERT S. SILVER, Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd., Philadelphia, PA, argued for defendants- appellees. Also represented by JAMES J. KOZUCH, SALVATORE GUERRIERO, PEI-RU WEY. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, REYNA, and CHEN, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 12, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.